J Cancer 2024; 15(9):2561-2572. doi:10.7150/jca.92386 This issue Cite

Research Paper

USP15 promotes the progression of papillary thyroid cancer by regulating HMGB1 stability through its deubiquitination

Si-si Wang1,2*, Dao-xiong Ye2*, Bo Wang1, Meng-yao Li1, Wen-xin Zhao1,2✉

1. Fujian Medical University, Fuzhou, Fujian 350001, P.R. China.
2. Department of Thyroid Surgery, Fujian Medical University Union Hospital, 29 Xinquan Road, Fuzhou, Fujian 350001, P.R. China.
* Co-first author: These authors contributed equally.

Citation:
Wang Ss, Ye Dx, Wang B, Li My, Zhao Wx. USP15 promotes the progression of papillary thyroid cancer by regulating HMGB1 stability through its deubiquitination. J Cancer 2024; 15(9):2561-2572. doi:10.7150/jca.92386. https://www.jcancer.org/v15p2561.htm
Other styles

File import instruction

Abstract

Graphic abstract

Purpose: Papillary thyroid cancer (PTC) stands as one of the most prevalent types of thyroid cancers, characterized by a propensity for in-situ recurrence and distant metastasis. The high mobility group protein (HMGB1), a conserved nuclear protein, plays a pivotal role in carcinogenesis by stimulating tumor cell growth and migration. Nevertheless, the underlying mechanism driving aberrant HMGB1 expression in PTC necessitates further elucidation.

Materials and methods: Our study unraveled the impact of low and overexpression of USP15 on the proliferation, invasion, and metastasis of PTC cells. Through a comprehensive array of molecular techniques, we uncovered the intricate relationship between HMGB1 and USP15 in the progression of PTC.

Results: In this study, we identified USP15, a deubiquitinase in the ubiquitin-specific proteases family, as a true deubiquitylase of HMGB1 in PTC. USP15 was shown to interact with HMGB1 in a deubiquitination activity-dependent manner, deubiquitinating and stabilizing HMGB1. USP15 depletion significantly decreased PTC cell proliferation, migration, and invasion. In addition, the effects induced by USP15 depletion could be rescued by further HMGB1 overexpression. But when HMGB1 is knocked down, even overexpression of USP15 could not promote the progression of PTC cells.

Conclusion: In essence, our discoveries shed light on the previously uncharted catalytic role of USP15 as a deubiquitinating enzyme targeting HMGB1, offering a promising avenue for potential therapeutic interventions in the management of PTC.

Keywords: PTC, USP15, HMGB1, deubiquitination


Citation styles

APA
Wang, S.s., Ye, D.x., Wang, B., Li, M.y., Zhao, W.x. (2024). USP15 promotes the progression of papillary thyroid cancer by regulating HMGB1 stability through its deubiquitination. Journal of Cancer, 15(9), 2561-2572. https://doi.org/10.7150/jca.92386.

ACS
Wang, S.s.; Ye, D.x.; Wang, B.; Li, M.y.; Zhao, W.x. USP15 promotes the progression of papillary thyroid cancer by regulating HMGB1 stability through its deubiquitination. J. Cancer 2024, 15 (9), 2561-2572. DOI: 10.7150/jca.92386.

NLM
Wang Ss, Ye Dx, Wang B, Li My, Zhao Wx. USP15 promotes the progression of papillary thyroid cancer by regulating HMGB1 stability through its deubiquitination. J Cancer 2024; 15(9):2561-2572. doi:10.7150/jca.92386. https://www.jcancer.org/v15p2561.htm

CSE
Wang Ss, Ye Dx, Wang B, Li My, Zhao Wx. 2024. USP15 promotes the progression of papillary thyroid cancer by regulating HMGB1 stability through its deubiquitination. J Cancer. 15(9):2561-2572.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image